This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Etubics Corporation. Active years: 2017-2022.
Company Filing History:
Years Active: 2017-2022
Title: Innovations by Elizabeth Gabitzsch
Introduction
Elizabeth Gabitzsch is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, holding a total of 10 patents. Her work focuses on developing methods and compositions that enhance immune responses, particularly through the use of adenovirus vectors.
Latest Patents
Among her latest patents are innovative methods for generating immune responses using adenovirus vectors. These methods allow for multiple vaccinations with the same adenovirus vector, even in individuals with preexisting immunity to adenovirus. Additionally, she has developed combination immunotherapies that utilize IL-15 superagonists. These compositions aim to generate enhanced immune responses by combining adenovirus vectors with an IL-15 superagonist complex, providing new avenues for treatment in subjects who require such interventions.
Career Highlights
Elizabeth Gabitzsch has established herself as a key figure in her field through her groundbreaking research and patent contributions. Her work at Etubics Corporation has positioned her at the forefront of immunotherapy innovations.
Collaborations
She collaborates with notable colleagues, including Frank R. Jones and Adrian Rice, who contribute to her research endeavors and the advancement of immunotherapy solutions.
Conclusion
Elizabeth Gabitzsch's innovative work in immunotherapy exemplifies the impact of her research on enhancing immune responses. Her patents and collaborations continue to pave the way for advancements in medical treatments.